Because the industry lacks a standardized UEL message wrapper, there’s little chance CMS/ONC can inject significant PCAST-report principles into Stage 2 of its Meaningful Use incentive program, according to Stan Huff and Dixie Baker, both members of the PCAST Workgroup, a subgroup of ONC’s HIT Policy Committee. Workgroup Chair Paul Egerman, a retired software entrepreneur, […]
More than 82 percent of CIOs say the voices of those who will have to implement MU (providers/vendors) are not being heard and acted on by the people crafting it, according to a recent healthsystemCIO.com SnapSurvey. Despite that widespread sentiment, the same percentage say they would be disappointed if the program were to be cancelled […]
With just under a year at the helm of Siemens Healthcare, it’s fair to say John Glaser has taken full measure of life on the vendor side. As such, he’s been immersed in issues like deciding which products are “go-forward,” which customer segments are best suited to the vendor’s offerings, and which industry regulations will […]
HITECH’s Meaningful Use Stage 2 requirements started their year-plus journey through federal advisory committees, regulation writers, public comment and countless revisions after a draft set of recommendations were floated for discussion at this month’s HIT Policy Committee meeting. Outlined by Paul Tang, M.D., vice chair of the committee and chair of its Meaningful Use Workgroup, the measures generally seek to increase thresholds established in Stage 1 as they climb to a Stage 3 apex.